Patents by Inventor Paul A. Moore

Paul A. Moore has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20170046365
    Abstract: A global user record that can be found in a search for posixAccount-type records is created in a database, then a zone user record of a type that cannot be found in a search for posixAccount-type records is associated with it. Finally, the zone user record is augmented so that it, too, will be found in a search for posixAccount-type records. Global and zone-specific group records are created similarly.
    Type: Application
    Filed: August 17, 2016
    Publication date: February 16, 2017
    Inventor: Paul Moore
  • Publication number: 20170016405
    Abstract: A control process for controlling an engine speed governor of an engine is provided. The process comprises the steps of calculating the current engine power being developed by the engine, and determining an appropriate engine speed for the current engine power based upon a first engine map. The process then instructs the speed governor to adjust the engine speed in accordance with the first map if required. The process monitors for desired engine power requests, and calculates a power ratio of desired engine power versus current engine power upon receiving a desired engine power request. The process then establishes an engine speed adjustment value based upon a second engine map of power ratio versus speed adjustment value, and instructs the speed governor to adjust the engine speed in accordance with the speed adjustment value. A speed governor system incorporating the control process, and a work machine or vehicle incorporating such a system are also provided.
    Type: Application
    Filed: February 12, 2015
    Publication date: January 19, 2017
    Applicant: Perkins Engines Company Limited
    Inventors: Paul Moore, William Carroll
  • Publication number: 20170009633
    Abstract: The present disclosure relates to a heating system for an exhaust gas treatment system. The heating system comprises a first heating element comprising a receiving surface for receiving a reductant fluid and a second heating element, which may surround the first heating element. The second heating element may be a thermochemincal or thermophysical device. In a first mode of operation the second heating element is arranged to receive thermal energy from engine exhaust gas. In second mode of operation the second heating element transfers thermal energy to heat the first heating element.
    Type: Application
    Filed: January 20, 2015
    Publication date: January 12, 2017
    Inventors: Ronald Silver, Paul Moore, Igor Strashny, David Heaton
  • Patent number: 9538333
    Abstract: Techniques where a computer system is able to obtain information about a subject by communicating with a device that employs a limited range communication technology and is associated with the subject are described.
    Type: Grant
    Filed: August 18, 2016
    Date of Patent: January 3, 2017
    Assignee: B2 Equity Holdings, Inc.
    Inventors: Bradley Alan Eaton, David Pyron Biggers, Jr., Dustin Paul Moore
  • Publication number: 20160360365
    Abstract: Techniques where a computer system is able to obtain information about a subject by communicating with a device that employs a limited range communication technology and is associated with the subject are described.
    Type: Application
    Filed: August 18, 2016
    Publication date: December 8, 2016
    Inventors: Bradley Alan Eaton, David Pyron Biggers, JR., Dustin Paul Moore
  • Publication number: 20160340425
    Abstract: Methods and compositions are provided for assessing, treating, and preventing diseases, especially cancer, using cancer-associated targets (“CAT”). Methods and compositions are also provided for determining or predicting the effectiveness of a treatment for these diseases or for selecting a treatment, using CAT. Methods and compositions are further provided for modulating cell function using CAT. Also provided are compositions that modulate CAT (e.g., antagonists or agonists), such as antibodies, proteins, small molecule compounds, and nucleic acid agents (e.g., RNAi and antisense agents), as well as pharmaceutical compositions thereof. Further provided are methods of screening for agents that modulate CAT, and agents identified by these screening methods.
    Type: Application
    Filed: December 7, 2015
    Publication date: November 24, 2016
    Inventors: Dong FANG, Paul MOORE, Steve RUBEN, Sudeepta AGGARWAL
  • Publication number: 20160332486
    Abstract: A tyre apparatus is provided, the apparatus including a tyre body for attachment to a wheel rim to define a first inflatable volume. An inner chamber defines a second inflatable volume which is located within the first inflatable volume of the tyre body. A first fluid communication path is provided between the first and second inflatable volumes and a second fluid communication path is provided between the first inflatable volume and the atmosphere. A first valve opens and closes the first fluid communication path, and a second valve opens and closes the second fluid communication path. The tensile strength and pressure-containing capacity of the material structure of the second inflatable volume is greater than that of the tyre first inflatable volume.
    Type: Application
    Filed: November 17, 2014
    Publication date: November 17, 2016
    Applicant: Caterpillar Inc.
    Inventors: Igor Strashny, Paul Moore
  • Publication number: 20160264672
    Abstract: The present invention relates to antibodies that are immunoreactive to the mammalian, and more particularly, the human B7-H3 receptor and to uses thereof, particularly in the treatment of cancer and inflammation. The invention thus particularly concerns humanized B7-H3-reactive antibodies that are capable of mediating, and more preferably enhancing the activation of the immune system against cancer cells that are associated with a variety of human cancers.
    Type: Application
    Filed: May 31, 2016
    Publication date: September 15, 2016
    Applicant: MacroGenics, Inc.
    Inventors: Leslie S. Johnson, Ling Huang, Paul A. Moore, Deryk T. Loo, Francine Zhifen Chen
  • Patent number: 9442962
    Abstract: A global user record that can be found in a search for posixAccount-type records is created in a database, then a zone user record of a type that cannot be found in a search for posixAccount-type records is associated with it. Finally, the zone user record is augmented so that it, too, will be found in a search for posixAccount-type records. Global and zone-specific group records are created similarly.
    Type: Grant
    Filed: January 23, 2007
    Date of Patent: September 13, 2016
    Assignee: CENTRIFY CORPORATION
    Inventor: Paul Moore
  • Patent number: 9441049
    Abstract: The present invention relates to antibodies that are immunoreactive to the mammalian, and more particularly, the human B7-H3 receptor and to uses thereof, particularly in the treatment of cancer and inflammation. The invention thus particularly concerns humanized B7-H3-reactive antibodies that are capable of mediating, and more preferably enhancing the activation of the immune system against cancer cells that are associated with a variety of human cancers.
    Type: Grant
    Filed: July 15, 2014
    Date of Patent: September 13, 2016
    Assignee: MacroGenics, Inc.
    Inventors: Leslie S. Johnson, Ling Huang, Paul A. Moore, Deryk T. Loo, Francine Z. Chen
  • Patent number: 9426623
    Abstract: Techniques where a computer system is able to obtain information about a subject by communicating with a device that employs a limited range communication technology and is associated with the subject are described.
    Type: Grant
    Filed: August 5, 2015
    Date of Patent: August 23, 2016
    Assignee: B3 Equity Holdings, Inc.
    Inventors: Bradley Alan Eaton, David Pyron Biggers, Jr., Dustin Paul Moore
  • Patent number: 9424420
    Abstract: Systems and methods for restricting application binary interfaces. An example method may comprise: initializing, by a process spawned by a kernel of an operating system running on a computer system, a system call filter inhibiting at least one type of application binary interface (ABI) calls; receiving a system call issued by a user space program executed by the computer system; intercepting the system call by the system call filter; determining that the system call is disabled by the system call filter; and performing a pre-determined action with respect to the system call.
    Type: Grant
    Filed: August 2, 2013
    Date of Patent: August 23, 2016
    Assignee: Red Hat, Inc.
    Inventors: Paul Moore, Dan Walsh, Lennart Poettering
  • Publication number: 20160222105
    Abstract: The present invention is directed to bi-specific monovalent diabodies that comprise two polypeptide chains and which possess at least one binding site specific for an epitope of CD3 and one binding site specific for an epitope of gpA33 (i.e., a “gpA33×CD3 bi-specific monovalent diabody”). The present invention also is directed to bi-specific monovalent diabodies that comprise an immunoglobulin Fc Domain (“bi-specific monovalent Fc diabodies”) and are composed of three polypeptide chains and which possess at least one binding site specific for an epitope of gpA33 and one binding site specific for an epitope of CD3 (i.e., a “gpA33×CD3 bi-specific monovalent Fc diabody”). The bi-specific monovalent diabodies and bi-specific monovalent Fc diabodies of the present invention are capable of simultaneous binding to gpA33 and CD3. The invention is directed to pharmaceutical compositions that contain such bi-specific monovalent diabodies or such bi-specific monovalent Fc diabodies.
    Type: Application
    Filed: August 20, 2014
    Publication date: August 4, 2016
    Applicant: MacroGenics, Inc.
    Inventors: Paul A. Moore, Jonathan Li, Francine Zhifen Chen, Leslie S. Johnson, Kalpana Shah, Ezio Bonvini
  • Publication number: 20160200827
    Abstract: The present invention is directed to sequence-optimized CD 123×CD3 bi-specific monovalent diabodies that are capable of simultaneous binding to CD 123 and CD3, and to the uses of such diabodies in the treatment of hematologic malignacies
    Type: Application
    Filed: August 20, 2014
    Publication date: July 14, 2016
    Applicant: MacroGenics, Inc.
    Inventors: Ezio Bonvini, Leslie S. Johnson, Ling Huang, Paul A. Moore
  • Publication number: 20160194396
    Abstract: The present invention is directed to bi-specific monovalent diabodies that comprise an immunoglobulin Fc Domain (“bi-specific monovalent Fc diabodies”) and are composed of three polypeptide chains and which possess at least one binding site specific for an epitope of CD32B and one binding site specific for an epitope of CD79b (i.e., a “CD32B×CD79b bi-specific monovalent Fc diabody”). The bi-specific monovalent Fc diabodies of the present invention are capable of simultaneous binding to CD32B and CD79b. The invention is directed to such compositions, to pharmaceutical compositions that contain such bi-specific monovalent Fc diabodies and to methods for their use in the treatment of inflammatory diseases or conditions, and in particular, systemic lupus erythematosus (SLE) and graft vs. host disease.
    Type: Application
    Filed: August 6, 2014
    Publication date: July 7, 2016
    Applicant: MacroGenics, Inc.
    Inventors: Leslie S. Johnson, Ling Huang, Kalpana Shah, Ezio Bonvini, Paul A. Moore, Wei Chen
  • Publication number: 20160161494
    Abstract: Methods and compositions for diagnosing and treating diseases, particularly cancer, associated with differential expression of cancer-associated targets (CAT) in disease cells compared to healthy cells are provided. Also provided are antagonists and agonists of CAT, and methods for screening agents that modulate CAT level or activity in vivo or in vitro.
    Type: Application
    Filed: June 19, 2015
    Publication date: June 9, 2016
    Inventors: Steve RUBEN, Karen VAN ORDEN, Bruno DOMON, Candy LEE, Tao HE, Mehdi MESRI, Elizabeth JOSELOFF, Katherine MCKINNON, Paul MOORE, Charles BIRSE
  • Patent number: 9358873
    Abstract: A transmission system for a hybrid vehicle includes a primary input shaft for receiving drive from a primary vehicle drive motor, such as an internal combustion engine. A secondary input shaft receives drive from a secondary vehicle drive motor, such as an electric motor. An output shaft of the system is connected to drive a final drive unit. A multi-speed gearbox is provided to connect the primary input shaft to the output shaft at one of a plurality of gear ratios. An input selection mechanism, in a first mode, connects the secondary input shaft to drive the output shaft and, in a second mode, connects the secondary input shaft to drive the primary input shaft. A clutch may be provided that can selectively connect or disconnect drive between the primary drive motor and the gearbox.
    Type: Grant
    Filed: July 11, 2012
    Date of Patent: June 7, 2016
    Assignee: Xtrac Limited
    Inventors: Adrian Paul Moore, Clive David Woolmer, Christopher Guy Cholmeley, Michael John Allen, Matthew Charles Clutterbuck, Paul Pomfret
  • Patent number: 9300690
    Abstract: Implementations for secure network labeling to control inter-process communications in a multi-tenant Platform-as-a-Service (PaaS) system are disclosed. A method of the disclosure includes initializing, by a processing device of a node, a gear of an application on the node, wherein the node hosts a plurality of gears for a plurality of applications of a multi-tenant Platform-as-a-Service (PaaS) system, and wherein the plurality of applications comprising multi-tenant applications having different owners. The method further includes determining a user identifier (UID) of the gear, generating a custom network security label (NSL) of the gear, assigning the custom NSL to the gear, and applying the custom NSL to an outgoing network packet sent from the gear to another gear within the PaaS system.
    Type: Grant
    Filed: July 3, 2013
    Date of Patent: March 29, 2016
    Assignee: Red Hat, Inc.
    Inventors: Daniel Walsh, Paul Moore
  • Publication number: 20160076466
    Abstract: A method of controlling exhaust gas temperature in an engine system including an internal combustion engine, a supercharger, a supercharger bypass arrangement and an exhaust aftertreatment module. The supercharger bypass arrangement is operable to selectively direct intake gas substantially to the supercharger or to direct the intake gas to the engine substantially bypassing the supercharger. The method includes determining an engine load and selectively controlling operation of the supercharger and supercharger bypass arrangement, based upon the engine load, to control the temperature of the exhaust gas to maintain it in a predetermined temperature range associated with the exhaust aftertreatment module.
    Type: Application
    Filed: September 1, 2015
    Publication date: March 17, 2016
    Applicant: PERKINS ENGINES COMPANY LIMITED
    Inventor: Paul Moore
  • Publication number: 20160002357
    Abstract: Bispecific heterodimeric diabody molecules and uses thereof in the treatment of cancer. The bispecific heterodimeric diabody molecules comprise two polypeptide chains that associate to form two epitope binding sites recognizing the P-cadherin tumor cell associated antigen and the CD3 T cell antigen.
    Type: Application
    Filed: June 26, 2015
    Publication date: January 7, 2016
    Applicant: PFIZER INC.
    Inventors: Chad Michael MAY, Adam Reid ROOT, William A. BRADY, Lioudmila Gennadievna TCHISTIAKOVA, Lidia MOSYAK, Laird BLOOM, Paul A. MOORE, Leslie S. JOHNSON